Director · Dianthus Therapeutics, Inc. /DE/ · Common Stock
Side
SELL
Value
$303K
Shares
2,800
Price
$108.38
Executed
Aug 10, 2026
Disclosed
Aug 11, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 10 executedAug 11, 2026 disclosed
DNTH · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
McGeorge Anne filed this Form 4 reporting a open-market sale of DNTH on Aug 10, 2026. It became public on Aug 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
McGeorge Annecik:0001779934
Issuer
Dianthus Therapeutics, Inc. /DE/cik:0001690585
Revision history · 0
No field has changed since this record was first ingested.
